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Abstract 
Background: Staphylococcus aureus is a major pathogen in skin and soft tissue infections.  Methicillin resistant S.aureus (MRSA) is prevalent in 
most of the countries wherever it is sought for. MRSA is one of the important pathogens implicated in hospital acquired infection. The main 
objectives of this study was to find out the antimicrobial susceptibility pattern of S.aureus isolates, the prevalence of methicillin resistant S.aureus 
(MRSA) and  nasal carriage rate in healthy hospital staff. Method: A total of 278 S.aureus strains isolated from clinical specimens were tested for 
antimicrobial susceptibility and 30 anterior nares swabs from healthy hospital staff were screened for S.aureus organisms using standard methods. 
Results: High resistance was observed against ampicillin, penicillin and tetracycline. High sensitivity was recorded against amikasin, amoxicillin-c 
and ciprofloxacin. Of the 278 isolates 26 (9%) isolates were methicillin resistant S.aureus (MRSA). 17 % of the hospital staff were positive for nasal 
carriage of Staphylococcus aureus. Conclusion: Our study emphasizes the need for continuous monitoring of the antimicrobial susceptibility 
pattern of S.aureus isolates including MRSA for the selection of appropriate therapy. In Eritrea, from the present findings it appears that the spread 
of MRSA in community and hospital settings is limited. 
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Background 
 
Staphylococcus aureus is a major pathogen implicated in skin and soft tissue infections. S.aureus also causes abscess in deep organs, responsible 
for toxin mediated diseases. This organism is one of the important pathogens in hospital acquired infection. In humans, colonization of S.aureus is 
found in the anterior nares. In general, nasal carriage rate is higher in hospital staff and patients than in the community. Nasal carriage of these 
organisms in hospital staff provides a source for infection in hospitalized patients especially in pediatric and intensive care units. Further, the 
development of multiple drug resistance to this organism is posing serious threat to inpatients especially in pediatric and intensive care units in 
hospital [1, 2]. With the world-wide emergence of methicillin resistant S.aureus (MRSA), as many of the MRSA isolates are multi drug resistant, 
these organisms are studied with special interest. MRSA cause nosocomial infections and are associated with increased rates of illness and death 
[3].   
  
Indiscriminate use of antibiotics and prolonged hospital stay are contributing factors in the emergence of multidrug resistant strains. With the 
emergence of MRSA and multi drug resistance, it is important to know the trend of antimicrobial resistance in any geographic area. Although, like 
elsewhere in the world, S.aureus is an important pathogen in the north-east region of Africa, the antimicrobial susceptibility pattern, prevalence of 
MRSA strains and carriage rate in healthy hospital staff are not known. There is no published data on these aspects. This study is an attempt to 
find answer to these questions.  
  
The main objectives of this work were to study the prevalence of S.aureus in clinical specimens, their antimicrobial susceptibility pattern and to 
assess the carriage rate of S.aureus in healthy hospital staff. 
 
 
Method 
 
The study was conducted in the Central Health laboratory, which serves as the National Reference Laboratory for Eritrea. Of the 278 clinical 
isolates, 272 isolates of S.aureus were from pus and 6 were from ear discharge. The anterior nares swabs were collected from 30 healthy hospital 
staffs who were working in the hospitals of Asmara (the capital city of Eritrea) at the time of the study.   
  
Standard procedures were followed to isolate, identify and perform antimicrobial susceptibility pattern [4, 5]. In brief, the specimens were collected 
in a culturette swab. The specimens were inoculated on Blood agar and Mannitol Salt agar (Oxoid) and were incubated at 37
o C for 18-24 hours. 
The suspected isolated colonies were subjected to Gram’s staining. S.aureus organisms were confirmed mainly by positive DNAse 
(deoxyribonuclease) and coagulase tests. Confirmed S.aureus isolates were subjected to antimicrobial sensitivity testing by standard disk diffusion 
method as per NCCLS standards [6].  
  
All confirmed S.aureus isolates were subsequently tested for methicillin resistance by using oxacillin disks (1 ug). The antimicrobials used were 
ampicillin (10 ug), amoxicillin-c (30 ug), ciprofloxacin (5 ug), cephalexin (30 ug), chloramphenicol (30 ug), cotrimaxozole (25 ug), gentamycin (10 
ug), erythromycin (15 ug), penicillin (10 U), amikasin (30 ug), and tetracycline (30ug).  American Type Culture Collection S.aureus 25923 was used 
as a reference strain. A total of 278 S.aureus isolates from patient specimens, and 5 isolates from 30 healthy hospital staff are included in this 
study.   
  
 
Results 
 
Antimicrobial susceptibility study of S.aureus isolates revealed high resistance to ampicillin (85%), penicillin (77%) and tetracycline (78%). Low 
resistance was observed against amoxicillin-c (8%), amikasin (7%) and ciprofloxacin (5%). 32% of the isolates were resistant to chloramphenicol 
and gentamycin. About 23 % of the S.aureus isolates were resistant to erythromycin (Table 1). Although our results were similar to some of the Page number not for citation purposes  3
other studies [7, 8], the antimicrobial resistance to different antimicrobials varies from place to place, time to time and also depends on a number 
of factors like use, abuse, availability and consumption of antibiotics. In general, high resistance was observed against widely used antibiotics like 
penicillin. This is evident when we compared the resistance to two aminoglycoside group antibiotics gentamycin (32%) which is widely used in our 
setting than amikasin (7%). In one of the large studies conducted [9], 88% of the isolates were resistant to penicillin whereas only 4% were 
resistance to tetracycline. 
 
Table 1: Antimicrobial susceptibility pattern of S.aureus isolates 
   S.aureus   ( n = 278) 
Antimicrobial  Number resistant  % resistant 
Amikasin 19  7 
Amoxycillin-c 22  8 
Ampicillin 236  85 
Cephalexin 73  26 
Chlorapmphenicol 89  32 
Ciprofloxacin 15  5 
Cotrimaxozole 95  34 
Erythromycin 214  23 
Gentamycin 89  32 
Oxacillin 26  9 
Penicillin 214  77 
Tetracycline 216  78 
 
 
In our study 26 (9%) of the S. aureus isolates were methicillin resistant (Table 2). All the methicillin resistant S. aureus were also resistant to 
penicillin while 96% were resistant to ampicillin. Low resistance was observed to amoxicillin-c (4%), cephalexin (8%), ciprofloxacin (8%), and 
amikasin (15%).  None of the 5 S.aureus isolates from healthy hospital staff was methicillin resistant. 
 
Table 2: Resistance pattern of Methicillin Resistant S.aureus isolates 
   MRSA   (n = 26) 
Antimicrobial  Number resistant  % resistant 
Amikasin 4  15 
Amoxycillin-c 1  4 
Ampicillin 25  96 
Cephalexin 2  8 
Chlorapmphenicol 7  27 
Ciprofloxacin 2  8 
Cotrimaxozole 6  23 
Erythromycin 7  27 
Gentamycin 12  46 
Oxacillin 26  100 
Penicillin 26  100 
Tetracycline 23  88 
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Discussion 
  
The MRSA prevalence rate shows high regional variance. This is indicated in different studies conducted in Croatia (22%), Taiwan (75- 84%), India 
(31-33%), Pakistan (83%), and Malaysia (40%) [9-15]. In USA there was progressive development of resistance to methicillin from 5% (1981) to 
52 % (2005). In the same study, high regional variation was found from 12.5 % to 100% [16]. Similarly, in Taiwan MRSA prevalence increased 
from 4.3 % (1981) to 84% (2000) [15]. A high prevalence of 83% MRSA is reported from Pakistan [9]. In contrast, the prevalence rate of MRSA 
was found to be low in France (6%), Ireland (5%) and United Kingdom (2%) [8].  
  
The antimicrobial susceptibility pattern of MRSA isolates also varies with place and time. In most of the studies conducted over the years, there 
was a clear indication of the progressive development of antimicrobial resistance to several antibiotics. In some of the studies, high resistance to 
ciprofloxacin was reported in MRSA isolates ranging from 46 to 99 %, [10-12] whereas in our study this was only 8 %. In Eritrea, ciprofloxacin is 
not widely used, and low resistance could be due to this factor. In Western Australia, high resistance was observed against erythromycin (60%) 
and ciprofloxacin (26%) among the MRSA isolates. The same study reported progressive development of ciprofloxacin resistance from 11% (1998) 
to 26 % (2002) [13]. High resistance development against erythromycin was reported (92%) in Taiwan [14]. In this study, among MRSA isolates, 
27% were resistant to erythromycin and 23 % to cotrimaxozole and high resistance (88%) was observed against tetracycline. The resistance rate 
to co-trimaxozole varies from 0- 66% [12, 13]. In some studies resistance to cotrimaxozole was as low as 0-1% and to tetracycline 6-9% [15, 17]. 
Our study emphasizes the need for continuous monitoring of antimicrobial resistance development in S.aureus isolates including MRSA. 
  
S. aureus is implicated in hospital acquired infection. Further, MRSA has emerged as a serious public health problem in all regions of the world. 
Community acquired MRSA infections occur as skin and soft tissue infections, whereas hospital acquired MRSA is acquired in hospitals and usually 
causes infections in the elderly, pediatric and immuno-compromised patients. At present, MRSA infections are treatable but there is a need to 
prevent the spread of MRSA in community and hospital settings. The best way to prevent the spread of S.aureus and MRSA in hospital settings is 
to screen health care takers for the presence of these organisms. The present study made an attempt to screen hospital staff for the S. aureus 
organisms. Of the 30 healthy hospital staff screened, 5 were positive for S.aureus and none of these was MRSA. The important reservoirs of MRSA 
in hospitals are infected patients and health care workers who are carriers. The carriage rate of S.aureus in healthy hospital staff ranges from 20-
76% in other studies [10, 11, 18-20]. This study records 17 % of nasal carriage for S.aureus.  
  
None of the 5 isolates of S.aureus obtained from hospital staff was methicillin resistant. Similar observation was made in other studies [15, 
16].This is contrary to other studies where  high carriage rate of 19-38% for MRSA is reported [8, 17, 18]. Some of the studies indicate that the 
epidemiology of MRSA is changing and hospitalization is no longer necessarily a risk factor [21, 22]. Although five isolates from 30 healthy hospital 
staff is very limited in numbers to draw a definite conclusion, our study also suggests this as far as MRSA is concerned. 
 
 
Conclusion 
 
In conclusion, our study emphasizes the need for continuous monitoring of the antimicrobial susceptibility pattern of S.aureus isolates including 
MRSA for the selection of appropriate therapy. When compared to the prevalence rate of MRSA in clinical isolates in other countries, it appears that 
in Eritrea, the spread of MRSA in community and hospital settings is limited. However, further molecular studies are recommended to study and 
monitor the epidemiology of multiple drug resistant S.aureus and MRSA. 
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